Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1238 |
|
| Actual shortage: | 52 (4%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1150 (93%) | |
Discontinuation Reports |
284 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 283 (100%) | |
| Reversed: | 1 (0%) | |
Late reports |
205 (13%) |
|
Overdue reports |
5 (10%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-CANDESARTAN | 8MG | TABLET | Resolved | 2019-07-05 | 2020-10-26 | 88585 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98796 |
| PMS-CANDESARTAN | 16MG | TABLET | Resolved | 2019-11-15 | 2020-06-10 | 98799 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2019-11-15 | 2020-05-19 | 98802 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2021-07-29 | 2021-08-30 | 143172 |
| PMS-CANDESARTAN | 4MG | TABLET | Resolved | 2023-04-14 | 2023-08-17 | 189598 |
| PMS-CANDESARTAN | 32MG | TABLET | Resolved | 2023-08-10 | 2023-09-18 | 201545 |
| PMS-CANDESARTAN | 32MG | TABLET | Actual shortage | 2024-03-15 | 2024-03-16 | 222369 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-05-04 | 2017-07-19 | 8925 |
| PMS-BUSPIRONE | 10MG | TABLET | Resolved | 2017-08-11 | 2018-05-05 | 18860 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2017-03-14 | 2017-11-23 | 2352 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2017-08-01 | 2017-11-23 | 17805 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Avoided shortage | 2019-03-29 | 2019-05-01 | 79878 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-05-09 | 2019-07-30 | 83732 |
| PMS-BUPRENORPHINE-NALOXONE | 2MG 0.5MG | TABLET | Resolved | 2019-06-11 | 2019-07-03 | 86234 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-06-28 | 2019-07-30 | 88025 |
| PMS-BUPRENORPHINE-NALOXONE | 8MG 2MG | TABLET | Resolved | 2019-10-04 | 2022-01-17 | 95445 |
| PMS-BRIMONIDINE | 0.2% | SOLUTION | Resolved | 2017-03-13 | 2020-04-02 | 1774 |
| PMS-BOSENTAN | 125MG | TABLET | Resolved | 2017-12-07 | 2018-02-17 | 32035 |
| PMS-BISACODYL | 10MG | SUPPOSITORY | Resolved | 2017-05-04 | 2020-06-10 | 8919 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6081 |
| PMS-SUMATRIPTAN | 50MG | TABLET | Discontinued | 2021-11-16 | 2021-11-16 | 149391 |
| PMS-SULFASALAZINE-E.C. TAB 500MG | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2021-03-01 | 2021-03-01 | 134853 |
| PMS-SOLIFENACIN | 5MG | TABLET | Reversed | 2020-06-15 | 2020-10-06 | 117915 |
| PMS-SOLIFENACIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117918 |
| PMS-SODIUM CROMOGLYCATE | 1% | SOLUTION | Discontinued | 2022-07-18 | 2023-04-12 | 164809 |
| PMS-SIMVASTATIN | 5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117804 |
| PMS-SIMVASTATIN | 10MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117807 |
| PMS-SIMVASTATIN | 20MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117810 |
| PMS-SIMVASTATIN | 40MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117815 |
| PMS-SIMVASTATIN | 80MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117849 |
| PMS-SERTRALINE | 100MG | CAPSULE | Discontinued | 2021-03-11 | 2021-03-11 | 135481 |
| PMS-ROPINIROLE | 1.0MG | TABLET | Discontinued | 2018-06-06 | 2018-06-07 | 51699 |
| PMS-ROPINIROLE | 0.25MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117897 |
| PMS-ROPINIROLE | 2.0MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117900 |
| PMS-ROPINIROLE | 5.0MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117903 |
| PMS-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118150 |
| PMS-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118153 |
| PMS-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118156 |
| PMS-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-06-17 | 2020-06-17 | 118159 |